LifeWorks Inc.
LWRK.TO
Toronto Stock Exchange32.27
CAD
+0.05
- -
LifeWorks Inc.
LWRK.TO
(Toronto Stock Exchange)
Recent
price
32.27
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- LifeWorks Inc, a provider of digital and in-person wellbeing solutions for employers, offers comprehensive services supporting the mental, physical, social and financial health of employees and their families through employee and family assistance programs (EFAP), total wellbeing platforms including iCBT guided services, absence and disability management, workers' compensation programs, health and wellness solutions, recognition and rewards programs, pension and benefits administration, retirement planning, actuarial services, investment consulting, compensation consulting, total rewards surveys, workplace training and workshops, children's support solutions and student support programs; the company operates via three segments comprising Integrated Health Solutions, Administrative Solutions, and Retirement and Financial Solutions, serving clients including 36 million employees and family members primarily in Canada, the United States, Australia, the United Kingdom, Brazil and other regions across more than 160 countries. Founded in 1966 and headquartered in Toronto, Ontario, Canada, LifeWorks (formerly Morneau Shepell, with the name change approved in May 2021) was acquired by TELUS Corporation in a C$2.9 billion transaction completed on September 1, 2022, becoming a wholly-owned subsidiary integrated into TELUS Health to enhance global digital health and wellness offerings with expanded scale, cross-selling synergies and technology unification; as of late 2025, the integration has delivered approximately C$417 million in combined annualized synergies including C$329 million from cost efficiencies and C$88 million from cross-selling, on track to reach a C$427 million target by year-end, bolstering employer-focused primary and preventative care solutions.